Virinchi Limited's promoter Viswanath Kompella has made a strategic acquisition of additional equity shares in the company. The transaction, completed on March 16, 2026, involved the purchase of 20,000 equity shares through open market operations, demonstrating continued confidence in the company's prospects.

Transaction Details

The share acquisition was formally disclosed under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The regulatory filing provides comprehensive details of the transaction and its impact on the promoter's overall shareholding pattern.

Shareholding Pattern Changes

The acquisition has resulted in a marginal increase in Kompella's shareholding across various parameters. His total shareholding has increased from 15.03% to 15.05% of the company's share capital, while his voting rights have grown from 11.29% to 11.31%.

Before Acquisition

After Acquisition

Company Capital Structure

Virinchi Limited's equity share capital structure remains unchanged following this transaction. The company maintains its existing capital base with no dilution from this promoter acquisition.

The disclosure indicates that the company has 1,72,50,000 outstanding warrants, which have been included in calculating the diluted share capital of 12,60,42,396 equity shares. This transaction reflects the promoter's continued commitment to the company while maintaining transparency through proper regulatory disclosures to both BSE Limited and NSE Limited.

Virinchi Limited has informed stock exchanges about a significant change in its subsidiary structure following the allotment of convertible equity warrants in Virinchi Health Care Private Limited. The transaction has resulted in the subsidiary ceasing to be a wholly-owned entity while continuing to remain a subsidiary under applicable regulations.

Warrant Conversion Details

The Board of Directors of Virinchi Health Care Private Limited allotted 52,22,000 convertible equity warrants to Viswanath Kompella, a promoter of the company, on March 03, 2026. The conversion process was completed in two phases, with each warrant converting into one fully paid-up equity share on a 1:1 basis.

Shareholding Pattern Changes

The allotment has significantly altered the ownership structure of Virinchi Health Care Private Limited. Prior to the transaction, Virinchi Limited held complete ownership of the subsidiary.

Financial Considerations

The preferential allotment generated total consideration of Rs. 7,83,30,000, with each convertible equity warrant priced at Rs. 15. The transaction was based on an enterprise valuation of Rs. 312.08 crore for Virinchi Health Care Private Limited, as determined by an independent registered valuer.

Subsidiary Performance Metrics

Virinchi Health Care Private Limited contributed significantly to the parent company's consolidated financials during 2024-25:

Regulatory Compliance

The transaction was executed following proper regulatory approvals. Virinchi Limited shareholders passed postal ballot resolutions on February 23, 2026, approving the related party investment and convertible equity warrant issuance. Subsequently, Virinchi Health Care Private Limited shareholders passed a special resolution on February 25, 2026, authorizing the preferential allotment to the promoter.

As a related party transaction involving a promoter, the allotment required shareholder approval through special resolution. Despite the change in ownership structure, Virinchi Health Care Private Limited continues to remain a subsidiary of Virinchi Limited under the provisions of the Companies Act, 2013 and SEBI Listing Regulations.